Product Information
CLOMIPRAMINE 75 MG CAPSULE is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.3645 per EA under NDC 27241021201. Its NADAC has been published 241 times since Feb 24, 2021.
FDA first approved this application on Oct 2, 2020.
The High Outlier badge above means this manufacturer's average price in the Clomipramine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
75 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241021201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
CLOMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213897FDA Approved
10/2/2020
On Market Since
12/23/2020
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPRAMINE 75 MG CAPSULE has been published 241 times since Feb 24, 2021, and over the history we have for it it has declined 82.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3645 per EA |
|---|---|
| All-time high | $2.1004 (Sep 15, 2021) |
| All-time low | $0.2871 (May 22, 2024) |
| Median price | $0.5601 |
| Average price | $0.7331 |
| Largest weekly change | +73.5% (Jun 19, 2024) |
| Weeks tracked | 241 |
| Tracking since | Feb 24, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-33.1%
5Y
-70.6%
All
-82.4%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ajanta Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clomipramine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOMIPRAMINE 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 75 MG CAPSULE, manufactured by Ajanta Pharma USA Inc., is $0.3645 per EA (NDC 27241021201), effective Oct 1, 2025.
How has the price of CLOMIPRAMINE 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLOMIPRAMINE 75 MG CAPSULE has declined 82.4%. It has been tracked across 241 weekly CMS publications since Feb 24, 2021.
What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 75 MG CAPSULE?
Since Feb 24, 2021, the NADAC for CLOMIPRAMINE 75 MG CAPSULE has ranged from a low of $0.2871 (May 22, 2024) to a high of $2.1004 (Sep 15, 2021), with a median of $0.5601 per EA.
Are there cheaper alternatives to CLOMIPRAMINE 75 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLOMIPRAMINE 75 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOMIPRAMINE 75 MG CAPSULE?
CLOMIPRAMINE 75 MG CAPSULE (NDC 27241021201) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.